Neurobrave

Company Overview

Snapshot

Founded in July 2020 by Dror Talisman and Oleg Aryutkin, Neurobrave operates with 11–50 employees. The company has raised $3 million across 4 funding rounds from 6 investors. In May 2024, Neurobrave received a grant from Google AI Startup Fund.

Business overview

Neurobrave develops a standardized software solution, NeuroSpeed OS, for analyzing neural biomarkers and insights. Leveraging cloud-based infrastructure, advanced signal processing, and proprietary deep neural network algorithms, the platform can process data from various hardware, including smartphones, smartwatches, and other wearables. Neurobrave's technology aims to reduce time to market for neuroscience ventures by automating biomarker extraction and analysis, serving industries such as manufacturing, gaming, and neurotechnology.

Strategic signal

In July 2024, Neurobrave's NeuroSpeed AI analysis software, which uses smartwatch sensors to track emotional well-being by analyzing heart rate variability, was highlighted for its B2B model and partnerships with insurance companies, healthcare providers, and wellness apps. This indicates strong market validation and a strategic focus on expanding its wearable technology integration and funding efforts, signaling significant growth potential in the mental health technology sector.

Company Intelligence Q&A

What is Neurobrave's core product?

Neurobrave's core product is NeuroSpeed OS, a standardized software solution that uses cloud-based infrastructure, advanced signal processing, and proprietary deep neural network algorithms to analyze neural biomarkers and insights from various hardware, including wearables like smartwatches.

Which companies has Neurobrave partnered with recently?

In July 2024, Neurobrave expanded its technology to other wearable devices and partnered with Qualcomm and Garmin. Additionally, in June 2024, its technology was integrated into Garmin wristbands and was on its way to being used in Sony headphones.

What is Neurobrave's collaboration with Sourasky Medical Center?

In April 2024, Neurobrave partnered with Sourasky Medical Center’s Functional Neurology Unit in Tel Aviv to accelerate research into complex neurological conditions, aiming to use AI for real-time translation of thoughts and intentions to help paralyzed patients communicate and operate devices.

Which investors participated in Neurobrave's November 2022 funding round?

In November 2022, Neurobrave received funding from Italian Angels for Growth and VentureIsrael.